Lymnox Life Sciences Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 2018.
2018 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Lymnox Life Sciences Private Limited

Lymnox Life Sciences Private Limited, a struck off private limited company, was established on 21 June 2018 in New Delhi, Delhi, India. Engaging in other services within the business services sector, it holds CIN: U74999DL2018PTC335624. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Jyoti Singh (Director), Rohit Kumar Singh (Director). Past directors included Binny Chopra. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at H-2/134A Mahavir Enclave Palam, New Delhi, Delhi, 110045.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999DL2018PTC335624

  • Registration Number

    335624

  • Incorporation Date

    21 June 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth **** %
  • Profit Growth **** -7.02%
  • Ebitda **** -11.97%
  • Net Worth -14.73%
  • Total Assets -3.01%
Company report

Lymnox Life Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lymnox Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lymnox Life Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Jyoti Singh Director 03 Sep 2018 Current
Rohit Kumar Singh Director 21 Jun 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lymnox Life Sciences.

Lymnox Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.73%.

Lymnox Life Sciences revenue growth over time
Lymnox Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -3.01%
*******
*******
*******
*******
Profit or Loss
*******
 -7.02%
*******
*******
*******
*******
Net Worth
*******
 -14.73%
*******
*******
*******
*******
EBITDA
*******
 -11.97%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lymnox Life Sciences?

Unlock access to Lymnox Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lymnox Life Sciences?

Unlock and access historical data on people associated with Lymnox Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lymnox Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lymnox Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lymnox Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    The activity Lymnox Life Sciences Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Lymnox Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Jyoti Singh was appointed as a Director was appointed as a Director on 03 Sep 2018 & has been associated with this company since 7 years 6 months . was documented.

  • Director Appointment

    The activity Rohit Kumar Singh was appointed as a Director was appointed as a Director on 21 Jun 2018 & has been associated with this company since 7 years 8 months . was completed.

  • Company Incorporation

    The activity Lymnox Life Sciences Private Limited was registered on 21 Jun 2018 with Roc Delhi & aged 7 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lymnox Life Sciences Private Limited?

The CIN of Lymnox Life Sciences Private Limited is U74999DL2018PTC335624.

Where is Lymnox Life Sciences Private Limited headquartered?

Lymnox Life Sciences Private Limited is headquartered at H-2/134A Mahavir Enclave Palam, New Delhi, Delhi, 110045.

When was Lymnox Life Sciences Private Limited incorporated?

Lymnox Life Sciences Private Limited was incorporated on 21 June 2018.

Who are the current directors of Lymnox Life Sciences Private Limited?

The current directors of Lymnox Life Sciences Private Limited are

What is the primary industry of Lymnox Life Sciences Private Limited?

The primary industry of Lymnox Life Sciences Private Limited is Business Services.

Is Lymnox Life Sciences Private Limited a listed company?

Lymnox Life Sciences Private Limited is unlisted.

What is the capital structure of Lymnox Life Sciences Private Limited?

The authorized capital of Lymnox Life Sciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available